We do not know. What we know is, it will either be CR before end Oct, receipts from income, or qtr expenditure less than last qtr that will see us into Q4. We all wait.
- Forums
- ASX - By Stock
- MNS
- Ann: ASIC Supplementary Submission to Senate Inquiry
Ann: ASIC Supplementary Submission to Senate Inquiry, page-154
-
- There are more pages in this discussion • 137 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add MNS (ASX) to my watchlist
|
|||||
Last
4.2¢ |
Change
0.000(0.00%) |
Mkt cap ! $50.37M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Featured News
MNS (ASX) Chart |
Day chart unavailable
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online